account_balance
Investment manager · 13F filer · SEC CIK 1582844
Acuta Capital Partners, LLC
Reported value$143Mas of Jun 30, 2026
Positions23 5 new, 8 sold out
Top 10 weight73.7%PRAX alone is 19%
FiledAug 1445 days after quarter end
Portfolio · as of Jun 30, 2026
Where the money is
New or addedTrimmedHeld
PRAXPraxis Precision Medicines I
19.3%Trimmed −2%
WHWKWhitehawk Therapeutics Inc
15.0%Added +37%
TNGXTango Therapeutics Inc
8.5%Trimmed −12%
STROSutro Biopharma Inc
6.3%
AVBPArrivent Biopharma Inc
5.3%New
FDMT4d Molecular Therapeutics Inc
4.7%New
DRUGBright Minds Biosciences Inc
4.5%Trimmed −17%
OCULOcular Therapeutix Inc
3.6%Trimmed −10%
ERASErasca Inc
3.4%Trimmed −25%
SRZNSurrozen Inc
3.1%
ARGX3.0%MLTX2.9%PRAXPraxis Precision Medicines I
19.3%Trimmed −2%
WHWKWhitehawk Therapeutics Inc
15.0%Added +37%
TNGX8.5%STRO6.3%AVBP5.3%FDMT4.7%DRUG4.5%OCUL3.6%ERAS3.4%SRZN3.1%ARGX3.0%MLTX2.9%Boxes show the top 12 stocks, sized against each other. The bar above shows how much of the fund they are. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
Show the top 12 as a list
PRAX Praxis Precision Medicines I 19.3% Trimmed −2%WHWK Whitehawk Therapeutics Inc 15.0% Added +37%TNGX Tango Therapeutics Inc 8.5% Trimmed −12%STRO Sutro Biopharma Inc 6.3% HeldAVBP Arrivent Biopharma Inc 5.3% NewFDMT 4d Molecular Therapeutics Inc 4.7% NewDRUG Bright Minds Biosciences Inc 4.5% Trimmed −17%OCUL Ocular Therapeutix Inc 3.6% Trimmed −10%ERAS Erasca Inc 3.4% Trimmed −25%SRZN Surrozen Inc 3.1% HeldARGX Argen Se - ADR 3.0% HeldMLTX Moonlake Immunotherapeutics 2.9% Added +12%
What changed